"Leukotriene E4" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A biologically active principle of SRS-A that is formed from LEUKOTRIENE D4 via a peptidase reaction that removes the glycine residue. The biological actions of LTE4 are similar to LTC4 and LTD4. (From Dictionary of Prostaglandins and Related Compounds, 1990)
| Descriptor ID |
D017999
|
| MeSH Number(s) |
D10.251.355.255.100.450.855.470 D10.251.355.310.166.887.855.470 D23.469.050.175.450.725.425
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Leukotriene E4".
Below are MeSH descriptors whose meaning is more specific than "Leukotriene E4".
This graph shows the total number of publications written about "Leukotriene E4" by people in this website by year, and whether "Leukotriene E4" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leukotriene E4" by people in Profiles.
-
Hoopes C. Invited commentary. Ann Thorac Surg. 2006 Sep; 82(3):1088-9.
-
Kane GC, Pollice M, Kim CJ, Cohn J, Dworski RT, Murray JJ, Sheller JR, Fish JE, Peters SP. A controlled trial of the effect of the 5-lipoxygenase inhibitor, zileuton, on lung inflammation produced by segmental antigen challenge in human beings. J Allergy Clin Immunol. 1996 Feb; 97(2):646-54.
-
Kane GC, Tollino M, Pollice M, Kim CJ, Cohn J, Murray JJ, Dworski R, Sheller J, Fish JE, Peters SP. Insights into IgE-mediated lung inflammation derived from a study employing a 5-lipoxygenase inhibitor. Prostaglandins. 1995 Jul; 50(1):1-18.
-
Landolfi R, Ciabattoni G, Patrignani P, Castellana MA, Pogliani E, Bizzi B, Patrono C. Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo. Blood. 1992 Oct 15; 80(8):1965-71.